21Feb 2023
A prospective, randomized trial comparing intravesical dimethyl sulfoxide (DMSO) to bupivacaine, triamcinolone, and heparin (BTH), for newly diagnosed interstitial cystitis/painful bladder syndrome (IC/PBS)

A prospective, randomized trial comparing intravesical dimethyl sulfoxide (DMSO) to bupivacaine, triamcinolone, and heparin (BTH), for newly diagnosed interstitial cystitis/painful bladder syndrome (IC/PBS)

This study aimed to compare the effectiveness of bladder instillations using dimethyl sulfoxide (DMSO) with triamcinolone versus bupivacaine, triamcinolone, and heparin (BTH) in women with newly diagnosed interstitial cystitis/painful bladder syndrome. The primary outcome was an improvement in symptoms measured using the O'Leary-Sant Interstitial Cystitis Symptoms Index (ICSI) score. Secondary outcomes included changes in urinary frequency, nocturia, and bladder capacity. A total of 70 participants completed the study (42 DMSO, 28 BTH), and the results indicated that DMSO and triamcinolone improved pain and nocturia compared to BTH. In addition, both groups showed a significant increase in bladder capacity.

  • #urology

Like

Save

Share